Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis

BACKGROUND: Using serum carbohydrate antigen 19–9 (CA 19–9) in discriminating between benign and malignant pancreatic disease remains controversial. We aim to evaluate the diagnostic value of serum CA 19–9 in predicting malignant pancreatic cystic lesions. METHODS: Eligible studies were identified t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Shaobo, Hu, Ya, Gao, Xiang, Liao, Quan, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105948/
https://www.ncbi.nlm.nih.gov/pubmed/27835676
http://dx.doi.org/10.1371/journal.pone.0166406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105948/
https://www.ncbi.nlm.nih.gov/pubmed/27835676
http://dx.doi.org/10.1371/journal.pone.0166406

Ejemplares similares